InflaRx Announces November Investor Events
Globe Newswire•27/10/2026•07:30 ET
0
Key Highlights
- ➤Q3 2026 financial and operating results scheduled for November 3 before market open
- ➤Capital Markets Day on November 3 to update AAV development strategy and anticipated clinical program
- ➤InflaRx to present izicopan’s potential safety advantages and differentiated properties in AAV
- ➤Guggenheim healthcare conference fireside chat scheduled for November 10
- ➤Jefferies healthcare conference investor meetings set for November 16 and 17
Jena, Germany, Oct. 27, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its events calendar for November.
Guggenheim Securities 3rd Annual Healthcare Innovation Conference November 9 – 11, 2026 in Boston, MA Fireside chat on November 10 at 9:30 AM EST InflaRx will also conduct one-on-one investor meetings on November 10th. A link to view the fireside chat live stream and its replay is available here.
Get started
Create a free account to read the full story.